Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer

This is an administrative response stating that no provider comments were received during the MolDX LCD DL38284 comment period (10/30/2019–12/24/2019). It records the notice period beginning 06/11/2020, the LCD effective date of 07/27/2020, and a title change from "MolDX: Razor 14-Gene Lung Cancer Assay" to "MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer."